Re: Results of a randomized trial of treatment modalities in patients with low or early‑intermediate risk prostate cancer (PREFERE trial)

J Cancer Res Clin Oncol. 2021 Apr;147(4):1271-1272. doi: 10.1007/s00432-020-03499-x. Epub 2021 Jan 28.

Abstract

The authors of this "Letter to the Editors" express their major concern about selective and biased reporting in this paper.

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Brachytherapy*
  • Humans
  • Male
  • Prostatectomy
  • Prostatic Neoplasms*